These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18221198)

  • 21. The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy.
    McGeer PL; McGeer EG
    Acta Neuropathol; 2013 Oct; 126(4):479-97. PubMed ID: 24052108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesterol and statins in Alzheimer's disease: current controversies.
    Fonseca AC; Resende R; Oliveira CR; Pereira CM
    Exp Neurol; 2010 Jun; 223(2):282-93. PubMed ID: 19782682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic approaches to Alzheimer's disease through stimulating of non-amyloidogenic processing of amyloid precursor protein.
    Wang YQ; Qu DH; Wang K
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2389-403. PubMed ID: 27338066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia.
    Pasinetti GM
    J Alzheimers Dis; 2002 Oct; 4(5):435-45. PubMed ID: 12446975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 mice.
    Yuan C; Guo X; Zhou Q; Du F; Jiang W; Zhou X; Liu P; Chi T; Ji X; Gao J; Chen C; Lang H; Xu J; Liu D; Yang Y; Qiu S; Tang X; Chen G; Zou L
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):161-180. PubMed ID: 30389579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activated human microglia stimulate neuroblastoma cells to upregulate production of beta amyloid protein and tau: implications for Alzheimer's disease pathogenesis.
    Lee M; McGeer E; McGeer PL
    Neurobiol Aging; 2015 Jan; 36(1):42-52. PubMed ID: 25169677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholesterol and the biology of Alzheimer's disease.
    Wolozin B
    Neuron; 2004 Jan; 41(1):7-10. PubMed ID: 14715130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential treatment opportunities for Alzheimer's disease through inhibition of secretases and Abeta immunization.
    Schenk D; Games D; Seubert P
    J Mol Neurosci; 2001 Oct; 17(2):259-67. PubMed ID: 11816797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Key Peptides and Proteins in Alzheimer's Disease.
    Penke B; Bogár F; Paragi G; Gera J; Fülöp L
    Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.
    Barage SH; Sonawane KD
    Neuropeptides; 2015 Aug; 52():1-18. PubMed ID: 26149638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel aβ isoforms in Alzheimer's disease - their role in diagnosis and treatment.
    Portelius E; Mattsson N; Andreasson U; Blennow K; Zetterberg H
    Curr Pharm Des; 2011; 17(25):2594-602. PubMed ID: 21728980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The recent updates of therapeutic approaches against aβ for the treatment of Alzheimer's disease.
    Ling S; Zhou J; Rudd JA; Hu Z; Fang M
    Anat Rec (Hoboken); 2011 Aug; 294(8):1307-18. PubMed ID: 21717585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drugs targeting Alzheimer's disease: some things old and some things new.
    Michaelis ML
    J Pharmacol Exp Ther; 2003 Mar; 304(3):897-904. PubMed ID: 12604663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient four-drug cocktail therapy targeting amyloid-β peptide for Alzheimer's disease.
    Asai M; Iwata N; Tomita T; Iwatsubo T; Ishiura S; Saido TC; Maruyama K
    J Neurosci Res; 2010 Dec; 88(16):3588-97. PubMed ID: 20890992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New therapies. New Alzheimer's treatments that may ease the mind.
    Helmuth L
    Science; 2002 Aug; 297(5585):1260-2. PubMed ID: 12193764
    [No Abstract]   [Full Text] [Related]  

  • 36. Alzheimer's disease therapeutics: new approaches to an ageing problem.
    Small DH; Losic D; Martin LL; Turner BJ; Friedhuber A; Aguilar MI
    IUBMB Life; 2004 Apr; 56(4):203-8. PubMed ID: 15230347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventions.
    Higuchi M; Iwata N; Saido TC
    Biochim Biophys Acta; 2005 Aug; 1751(1):60-7. PubMed ID: 16054018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigational medications for treatment of patients with Alzheimer disease.
    Potter PE
    J Am Osteopath Assoc; 2010 Sep; 110(9 Suppl 8):S27-36. PubMed ID: 20926740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protease inhibitors as potential disease-modifying therapeutics for Alzheimer's disease.
    Beher D; Graham SL
    Expert Opin Investig Drugs; 2005 Nov; 14(11):1385-409. PubMed ID: 16255678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer's disease drug development based on Computer-Aided Drug Design.
    Zeng H; Wu X
    Eur J Med Chem; 2016 Oct; 121():851-863. PubMed ID: 26415837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.